Junwei Hao
Junwei Hao publishes mostly in Neurology, Molecular Biology and Immunology, on topics such as Neuroinflammation and Neurodegeneration Mechanisms, Multiple Sclerosis Research Studies and Neurological Disease Mechanisms and Treatments.
- World rank
- #66,411 of 7,710,434 ranked researchers
- Rank in China
- #5,228 of 978,568
- Works
- 154
- Citations
- 9.4k
- Citations per work
- 61.3
What does Junwei Hao research?
Junwei Hao's work is mostly in Medicine (18%), Biochemistry, Genetics and Molecular Biology (16%), Neuroscience (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences6341.0%
- Biochemistry, Genetics and Molecular Biology2516.4%
- Neuroscience2013.0%
- Immunology and Microbiology1811.6%
- Everything else6340.8%
- Health Sciences2818.2%
- Medicine2818.2%
- 1Neurology13% of their works
- 2Molecular Biology12% of their works
- 3Immunology12% of their works
- 4Neurology12% of their works
- 5Pathology and Forensic Medicine7% of their works
- 6Cancer Research4% of their works
Research topics
- Neuroinflammation and Neurodegeneration Mechanisms
- Multiple Sclerosis Research Studies
- Neurological Disease Mechanisms and Treatments
- Peripheral Neuropathies and Disorders
- Acute Ischemic Stroke Management
- Cancer-related molecular mechanisms research
- Immune Cell Function and Interaction
- Intracerebral and Subarachnoid Hemorrhage Research
Which keywords describe Junwei Hao's research?
The keywords of their largest research topics: Ischemic Stroke, Neuroinflammation, Microglia, Neurodegeneration, Diagnostic Criteria, Multiple Sclerosis, Cerebral Hypoperfusion and Vascular Cognitive Impairment.
- Intracerebral Hemorrhage
- Natural Killer Cells
- Long Noncoding RNAs
- Thrombolysis
- Guillain-Barré Syndrome
- Vascular Cognitive Impairment
- Multiple Sclerosis
- Neurodegeneration
- Neuroinflammation
- Ischemic Stroke
- Microglia
- Diagnostic Criteria
- Cerebral Hypoperfusion
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Endovascular Therapy
- Cancer
- NK Cell Recognition
- Cerebral Amyloid Angiopathy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Ischemic Stroke452 topics
- Neuroinflammation422 topics
- Microglia331 topic
- Neurodegeneration331 topic
- Diagnostic Criteria201 topic
- Multiple Sclerosis201 topic
- Cerebral Hypoperfusion151 topic
- Vascular Cognitive Impairment151 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy141 topic
- Guillain-Barré Syndrome141 topic
- Endovascular Therapy121 topic
- Thrombolysis121 topic
- Cancer111 topic
- Long Noncoding RNAs111 topic
- NK Cell Recognition111 topic
- Natural Killer Cells111 topic
- Cerebral Amyloid Angiopathy91 topic
- Intracerebral Hemorrhage91 topic
Where does Junwei Hao work?
Junwei Hao's main affiliation in the publication record is Tianjin Medical University General Hospital, China.
How many publications and citations does Junwei Hao have?
OpenAlex counts 154 works and 9,438 citations for Junwei Hao, an h-index of 50, ranking #66,411 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Junwei Hao. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.